Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™-Reference-Cited by-同舟云学术

Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™

Published:2015-02 Issue:7 Volume:33 Page:924-932
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Leonardi Michael,Latiolais Thomas,Sarpong Kwabena,Simon Michael,Twiggs Jerry,Lei Paul,Rinderknecht Stephen,Blatter Mark,Bianco Veronique,Baine Yaela,Friedland Leonard R.,Baccarini Carmen,Miller Jacqueline M.

Funder

GlaxoSmithKline Biologicals SA

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference42 articles.

1. Meningococcal disease;Rosenstein;N Engl J Med,2001

2. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal disease;Cohn;Clin Infect Dis,2010

3. Global epidemiology of meningococcal disease;Harrison;Vaccine,2009

4. Global epidemiology of meningococcal disease and vaccine efficacy;Pollard;Pediatr Infect Dis J,2004

5. The epidemiology of meningococcal disease and the impact of vaccines;Khatami;Expert Rev Vaccines,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT;Expert Review of Vaccines;2021-09-01

2. MenQuadfi (MenACWY-TT): A New Vaccine for Meningococcal Serogroups ACWY;Annals of Pharmacotherapy;2021-08-29

3. A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States;Vaccine;2020-04

4. The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial;Vaccine;2019-09

5. Identification of potential biomarkers of vaccine inflammation in mice;eLife;2019-05-14